CAPR Competitors & Alternatives

Compare Capricor Therapeutics Inc with similar stocks in the same industry

Biotechnology

CAPR

Main Stock
$8.47
-11.12%
Tradestie Score
28
Market Cap
$357.51M
Revenue Growth
-7.9%
Analyst Upside
+221.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Cell Therapy
Competitive Moat: None
Core Technology Stack: CAP-1002 allogeneic cardiosphere-derived cells, exosome platform
Major Customers 2
clinical research centers future DMD patients
Critical Suppliers 2
manufacturing CMOs raw material providers for biologics
Direct Ecosystem Rivals 3

Top Competitors

220 stocks in Biotechnology
Company Price Market Cap P/E Score Action
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
+0.04%
$683.46M - 49 Compare
ANL ANL
$9.97
-6.03%
$677.47M - 48 Compare
MGTX MeiraGTx Holdings plc Ordinary Shares
$8.85
-3.59%
$665.30M 10.1 46 Compare
ERAS Erasca, Inc. Common Stock
$14.95
-4.57%
$626.91M - 35 Compare
SVRA Savara Inc.
$4.43
-4.63%
$611.84M - 56 Compare
KALV KalVista Pharmaceuticals, Inc. Common Stock
$27.00
+0.04%
$608.81M - 49 Compare
VSTM Verastem, Inc.
$7.88
-3.67%
$541.60M - 54 Compare
CRVS Corvus Pharmaceuticals, Inc.
$10.55
-0.85%
$540.97M - 34 Compare
ZVRA Zevra Therapeutics, Inc. Common Stock
$9.31
+2.53%
$529.35M 9.7 56 Compare
LXRX Lexicon Pharmaceuticals, Inc.
$1.75
-2.51%
$512.39M - 37 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

220 stocks in this industry